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Minus-strand transferThe HIV-1 Gag polyprotein precursor has multiple domains including nucleocapsid (NC). Although mature
NC and NC embedded in Gag are nucleic acid chaperones (proteins that remodel nucleic acid structure), few
studies include detailed analysis of the chaperone activity of partially processed Gag proteins and
comparison with NC and Gag. Here we address this issue by using a reconstituted minus-strand transfer
system. NC and NC-containing Gag proteins exhibited annealing and duplex destabilizing activities required
for strand transfer. Surprisingly, unlike NC, with increasing concentrations, Gag proteins drastically inhibited
the DNA elongation step. This result is consistent with “nucleic acid-driven multimerization” of Gag and the
reported slow dissociation of Gag from bound nucleic acid, which prevent reverse transcriptase from
traversing the template (“roadblock” mechanism). Our ﬁndings illustrate one reason why NC (and not Gag)
has evolved as a critical cofactor in reverse transcription, a paradigm that might also extend to other
retrovirus systems.C BY-NC-ND license. ublished by Elsevier Inc. Open access under CC BY-NC-ND license. Introduction
The human immunodeﬁciency type 1 (HIV-1) Gag polyprotein
precursor is the only viral protein required for assembly of virus-like
particles (VLPs) (reviewed in Freed, 1998; Swanstrom andWills, 1997;
Vogt, 1997). Monomeric Gag is a 55-kDa multi-domain protein, which
contains (from the N- to C-terminus) matrix (MA), capsid (CA), spacer
peptide 1 (SP1), nucleocapsid (NC), spacer peptide 2 (SP2), and p6
(Henderson et al., 1992) (reviewed in Adamson and Freed, 2007; Freed,
1998; Turner and Summers, 1999; Vogt, 1997) (Fig. 1A). Each of the
domains contributes to the overall activity of Gag and to its unique role in
HIV-1 replication. For example, the MA domain is responsible for Gag
targeting to the plasma membrane during virus assembly and also binds
RNA (Adamson and Freed, 2007; Chukkapalli et al., 2010; Shkriabai et al.,
2006). CA is a protein interaction domain that facilitates Gag multi-
merization (Datta et al., 2007a,b; Gamble et al., 1997); the NC domain
binds RNA, is required for genomic RNA packaging and primer placement
(Darlix et al., 1995; Kleiman and Cen, 2004; Levin et al., 2005; Rein et al.,
1998), has a role in viral RNA dimerization (Darlix et al., 1990; Feng et al.,
1999; Liang et al., 1998), and interacts with the Bro 1 domain of the hostprotein Alix during virus assembly (Dussupt et al., 2009; Popov et al.,
2009); and the p6 domain is needed for virus release and interactionwith
host factors in the ESCRT pathway (Adamson and Freed, 2007). During or
shortly after budding of virions from the cell, the viral protease (PR) is
activated and Gag is cleaved into the virus structural proteins. Cleavage
occurs sequentially and in a highly ordered manner (Adamson and
Freed, 2007; Freed, 1998; Swanstrom and Wills, 1997; Vogt, 1997).
ThematureNC protein, which is released in a late cleavage reaction
(Swanstrom and Wills, 1997), plays a major role in assuring the
speciﬁcity and efﬁciency of reverse transcription (reviewed in Bampi
et al., 2004; Darlix et al., 1995; Levin et al., 2005; Rein et al., 1998;
Thomas and Gorelick, 2008) and is also important for other events in
the virus life-cycle including maturation of the genomic RNA dimer
(Feng et al., 1996; Muriaux et al., 1996) and integration of proviral DNA
into the host genome (Carteau et al., 1999; Thomas et al., 2006). NC's
function in virus replication is correlated with its ability to act as a
nucleic acid chaperone. This activity allows NC to catalyze nucleic acid
conformational changes that result in the most thermodynamically
stable structures (Tsuchihashi andBrown, 1994; reviewed in Levin et al.,
2005; Rajkowitsch et al., 2007; Rein et al., 1998). The NC domain in Gag
also has nucleic acid chaperone activity and asmentioned above, its role
in viral DNA synthesis is to mediate primer placement, i.e., annealing of
the tRNA3Lys primer to the viral RNA genome, a reaction that occurs
Fig. 1. HIV-1 Gag proteins and reconstituted model system used for assay of minus-strand transfer. (A) Schematic representation of WT and mutant HIV-1 Gag proteins as well as Gag-
derived cleavageproducts. GagΔp6 (Campbell and Rein, 1999)was used as the source ofWTGag. The asterisk inGagWMindicates that residues Trp316 andMet317 in theCTD of CAwere
mutated to Ala (Datta et al., 2007b). Partial deletion of the MA domain in GagΔ16-99 (Datta and Rein, 2009; Gross et al., 2000) is shown as a dashed line. Each of the domains in Gag is
labeled and represented by open, closed, or gray rectangles. (B) Gel analysis of puriﬁed Gag and Gag-derived proteins used in this work. The proteins were analyzed on a 4–12% gradient
SDS–polyacrylamide gel. The amounts of protein loaded on the gel were as follows: MA, 40 μg; CA, 20 μg; MACA, 20 μg; CANC, 20 μg; GagΔ16-99, 25 μg; Gag WM, 25 μg; GagΔp6, 20 μg.
Molecularmarkerswere runon the samegel toverify themolecularmassof theHIV-1proteins and thepositionsof themarkers are shownto the left of thegel image. For eachof the testproteins,
the residue numbers in Gag and the respective molecular mass values were as follows: MA (1–131, 14.8 kDa); CA (132–362, 25.6 kDa); MACA (1–362, 40.3 kDa); CANC (132–431, 33.5 kDa);
GagΔ16-99 (1–15 and 100–447, 40.3 kDa); GagWM (1–447, 49.9 kDa); and Gag (1–447, 50.0 kDa). Note that p6 is not present in any of the Gag proteins (seeMaterials andmethods section,
“Puriﬁcationof proteinsused in this study”). (C) Schematic diagram illustrating the reconstituted systemused for assayofminus-strand transfer (Heilman-Miller et al., 2004). Thediagramshows
annealingof the94 complementarybases in theR regions of theRNA148acceptor and 33P-labeledDNA128. The54-nt sequence fromU3 in acceptorRNAserves as the template forRT-catalyzed
DNA extension. The ﬁnal DNA transfer product is 182 nt. The diagrams in A and C are not drawn to scale.
557T. Wu et al. / Virology 405 (2010) 556–567during virus assembly (Cen et al., 1999, 2000; Feng et al., 1999; Huang
et al., 1997; Kleiman and Cen, 2004).
Previous studies of the chaperone activities of Gag and NC have not
generally included detailed comparison with the activities of partially
processed Gag proteins. To address this issue, we examined the activity of
wild-type (WT) and mutant Gag and Gag-derived proteins to determine
how chaperone activity is affected by removing one or more domains
from Gag. Experimentally, our approach was to use our reconstituted
minus-strand transfer assay system, which models the NC-dependent
transfer of (−) strong-stop DNA [(−) SSDNA] to the 3′ end of the viral
RNA genome, in a reaction facilitated by annealing of the complementary
repeat regions in the RNA and DNA substrates (Basu et al., 2008; Levin et
al., 2005; Thomas and Gorelick, 2008). This system represents a rigorous
test for chaperone function (Guo et al., 1997; Heilman-Miller et al., 2004)
and can also be used to examine the nucleic acid chaperone activity of
proteins other than HIV-1 NC (Zúñiga et al., 2010).Here, our results demonstrate that only Gag and partially processed
Gag proteins containing the NC domain have nucleic acid chaperone
activity. Although the activities of these proteins share some properties
in common with mature NC, there are also fundamental differences.
Thus, like NC, Gag and Gag-derived proteins exhibit annealing and
duplex destabilizing activities that are required for minus-strand
transfer. Surprisingly, as the protein concentration is increased, NC
stimulates strand transfer, whereas Gag proteins drastically inhibit
strand transfer (speciﬁcally, the DNA elongation step) by apparently
blocking reverse transcriptase (RT) movement along the template. We
refer to this inhibition as the “roadblock mechanism”. Moreover,
endogenous RT (ERT) assays of minus-strand transfer with detergent-
treated HIV-1 virions havingmutations at one ormore PR cleavage sites
(Wyma et al., 2004) give results consistent with data obtained with the
reconstituted system. Collectively, our studies provide additional
insights into the question of why mature NC (and not a precursor) has
558 T. Wu et al. / Virology 405 (2010) 556–567evolved as a critical cofactor that facilitates efﬁcient and speciﬁc HIV-1
reverse transcription.
Results
Nucleic acid chaperone activity of Gag and Gag WM proteins facilitate
minus-strand transfer
In the present study, we set out to determine functional differences
between the nucleic acid chaperone activities of NC embedded within
larger precursors and mature NC. Our approach was to investigate the
activities of unprocessed Gag and partially processed Gag proteins and to
compare these activitieswith that ofNC (Figs. 1A andB). For thiswork,we
used our reconstituted minus-strand transfer assay system (Fig. 1C),
which represents an especially sensitive readout for chaperone function
(Guo et al., 1997; Heilman-Miller et al., 2004). This system measures (i)
annealing of the RNA 148 acceptor to (−) SSDNA (i.e., DNA 128), which
requires nucleic acid aggregation activity aswell as helix destabilization of
the highly structured complementary trans-activation response element
(TAR) stem-loops at the 3′ ends of the repeat regions in (−) SSDNA andFig. 2. Effect of HIV-1 NC and Gag proteins onminus-strand transfer. (A) Gel analysis. Reaction
concentrations of HIV-1 NC (lanes 2 to 5). In parallel sets of reactions, DNA 128 was incubate
concentrations of WT Gag (lanes 7 to 12) or Gag WM (lanes 14 to 19). The protein concentrat
represents a control reaction inwhich acceptor and NC or Gagwere omitted. Only SP products a
Bar graphs showing the percentage (%) of minus-strand transfer product (B) or SP products (
protein, open bars; HIV-1 NC, closed bars; Gag, gray bars; Gag WM, hatched bars; C, cross-hatacceptor RNA; (ii) RT-catalyzed elongation of annealed (−) SSDNA, using
the 54-nt U3 region present in the acceptor as the template, to give a 182-
nt transfer product; and (iii) a competing reaction, known as self-priming
(SP), inwhich fold-back structures at the3′endof (−) SSDNA(inducedby
the presence of the DNA TAR stem-loop) are extended by RT, forming a
heterogeneous mixture of dead-end SP products (Beltz et al., 2005;
Driscoll and Hughes, 2000; Guo et al., 1997, 2000; Heilman-Miller et al.,
2004; Lapadat-Tapolsky et al., 1997; Levin et al., 2005 and references
therein). In these experiments, “Gag” refers to the protein known as
GagΔp6 (Campbell and Rein, 1999).
To evaluate the chaperone activities of HIV-1 Gag and Gag WM, a
mutant with poor protein dimerization activity (Datta et al., 2007a,b),
we tested the effect of increasing protein concentration on minus-
strand transfer (Fig. 2). A similar set of reactions with HIV-1 NC was
included as a positive control. The strand transfer and SP products
were resolved by polyacrylamide gel electrophoresis (PAGE) (Fig. 2A)
and were quantiﬁed by PhosphorImager analysis of the gel data (Figs.
2B and C, respectively). SP products were identiﬁed by comparison
with the bands formed in a control reaction (C), which lacks acceptor
and NC (Guo et al., 1997; Heilman-Miller et al., 2004).mixtures were incubated for 60 min in the absence (No, lane 1) or presence of increasing
d with RNA 148 for 60 min in the absence (No, lanes 6 and 13) or presence of increasing
ions for each set of reactions are indicated at the bottom of the ﬁgure. The lane labeled C
re formed under these conditions (Guo et al., 1997; Heilman-Miller et al., 2004). (B and C)
C) synthesized as a function of NC, Gag, or Gag WM protein concentrations. Symbols: no
ched bar.
Fig. 3. Stimulation of the minus-strand annealing reaction by HIV-1 NC, Gag, and Gag WM proteins. Reaction mixtures were incubated for 30 min at 37 °C under the conditions
described inMaterials andmethods. Bar graphs show the % of DNA 128 that was annealed in the absence (No, open bars) or presence of increasing concentrations of NC (closed bars),
Gag (gray bars), or Gag WM (hatched bars).
Table 1
Apparent dissociation constants for binding of NC and Gag to 20-nt ssDNA and ssRNA
oligonucleotides.
Protein Kd (nM)
DNA RNA
NC 143±12a 108±23
Gag 9±1 8±1
Gag WM 20±0.1 23±1
a The error determinations represent the SD.
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et al., 2004), increasing concentrations of NC dramatically stimulat-
ed synthesis of the strand transfer product and severely inhibited
SP (Figs. 2B and C, compare lanes 2 to 5 with lane 1). Gag and Gag
WM also exhibited strand transfer activity in a dose-dependent
manner, but signiﬁcant activity occurred over a very narrow range
(0.08–0.12 μM) (lanes 9 and 10 and lanes 16 and 17, respectively).
At Gag and Gag WM concentrations that support strand transfer
(i.e., up to 0.12 μM), inhibition of SP was more modest than that
observed with NC (Fig. 2C), implying that the duplex destabilizing
activity of Gag is not as effective as that of NC. At higher
concentrations of Gag proteins, SP was drastically reduced, but as
explained below, this is due to a general reduction in RT-catalyzed
DNA extension. Gag WM facilitated strand transfer only slightly
more efﬁciently than Gag (Fig. 2B, compare lanes 16 and 17 with
lanes 9 and 10). This would suggest at ﬁrst glance that the oligomeric
status of these proteins might be the same under the conditions of this
assay (for further discussion of this point, see below.)
Comparison of the NC, Gag, and GagWMresults showed that a higher
concentration of NCwas needed to achieve maximal strand transfer than
was required for the Gag proteins (3.2 μM NC vs. 0.12 μM Gag or Gag
WM). However, the percent strand transferwith NCwas ~1.5-fold higher
than the values obtained for reactions with the two Gag proteins.
Curiously, in contrast to NC's behavior (Fig. 2B, lanes 4 and 5), when the
concentration of Gag orGagWMwas raised, e.g., to 0.23 μM(Fig. 2B, lanes
11 and 18, respectively), there was a substantial reduction in strand
transfer activity. At 0.46 μM, strand transfer activity was completely
inhibited (Fig. 2B, lanes 12 and 19, respectively). In additional reactions
with 0.46 μM Gag and increasing concentrations of RT from 20 to 50 nM
(in our assay we use 10 nM), strand transfer was slightly increased, but
not to an appreciable extent (e.g., 20 nM RT, b10%; 50 nM RT, 15%)
(data not shown).
Since the minus-strand transfer assay requires both annealing and
DNA elongation for a positive readout (Fig. 1C), it was important to
determine which of these steps might be affected by increased
concentrations of Gag and Gag WM.We therefore measured annealing
alone as a function of protein concentration (Fig. 3). The data showed
that for NC, Gag, and Gag WM, increasing the protein concentration
resulted in a greater extent of annealing. In contrast to the strand
transfer results, annealing with both Gag proteins did not lead to a
reduction in the percent annealed product, even at the concentration
(0.46 μM) at which strand transfer was completely abolished (Fig. 2).
Moreover, heat annealing of RNA 148 to DNA 128 followed by addition
of increasing concentrations of Gag plus a constant amount of RT led to
results similar to those presented in Fig. 2B, i.e., inhibition of strand
transfer (data not shown).Taken together, these ﬁndings clearly demonstrate that the
observed inhibition of strand transfer is caused by an inhibition of
RT-catalyzed DNA extension and not annealing. Thus, when strand
transfer was inhibited (concentrations of Gag and Gag WM above
0.12 μM), the reduction in SP (Fig. 2C, lanes 12 and 19) was due to a
general reduction of polymerase activity and not to the helix
destabilizing activity of the Gag proteins. In addition, as will be
discussed in detail below, the data suggest that binding of Gag
proteins to single-stranded (ss) nucleic acids creates a “roadblock”,
which signiﬁcantly reduces the ability of RT to traverse the template.
The results of Fig. 3 also show that with NC and the two Gag
proteins, the annealing reaction reached an end point of ~60% in each
case. However, the amount of Gag or Gag WM required for maximal
activity (0.16 μM) was considerably lower than the amount of NC
needed (between 1.6 and 3.2 μM). To account for this difference, we
used FA to measure the nucleic acid binding afﬁnity of Gag and NC to
ss 20-nt DNA and RNA oligonucleotides (Table 1). In accord with the
data of Fig. 3, we found that under our conditions, Gag was bound to
nucleic acid ~15-fold more efﬁciently than NC (Table 1), e.g., the
apparent dissociation constant (Kd) values for binding to the DNA
oligonucleotide were 9±1 nM (Gag) vs. 143±12 nM (NC). The Kd
values for GagWM (with DNA, 20±0.1) were similar to those of Gag,
as expected from the data of Fig. 3. Note that in each case, the Kd
values for binding to the RNA and DNA substrates were very similar.
Relative contributions of MA and NC to Gag nucleic acid chaperone
activity
Like NC, the MA domain in Gag also binds nucleic acids (Adamson
and Freed, 2007; Vogt, 1997). It was therefore of interest to ascertain
whether the MA domain contributes to Gag nucleic acid chaperone
activity. To address this question, we initially assayed the strand
transfer activity of three proteins lacking the NC domain (Fig. 4A), i.e.,
Fig. 4.Minus-strand transfer activity of HIV-1 MA, CA, and MACA proteins in the absence or presence of HIV-1 NC added in trans. 33P-labeled DNA 128 was incubated with RNA 148
for 60 min in the absence or presence of increasing concentrations of MA (2 to 5), CA (7 to 10), and MACA proteins (12 to 15). (A) and (B) Bar graphs show the % of minus-strand
transfer product synthesized as a function of the protein concentrations of MA, CA, andMACA in the absence (A) or presence of (B) 0.92 μMNC added in trans. Symbols: open bars, no
protein; gray bars, NC only; and closed bars, increasing concentrations of MA, CA, and MACA (concentrations indicated at the bottom of the ﬁgure).
560 T. Wu et al. / Virology 405 (2010) 556–567MA (lanes 1 to 5), CA (lanes 6 to 10), and MACA (lanes 11 to 15). MA
and CA had no detectable nucleic acid chaperone activity at
concentrations similar to those used for Gag and Gag WM. MACA
had a very small stimulatory effect at the highest concentrations of the
protein (lanes 14 and 15), but the level of activity was too low to be
considered signiﬁcant.
We also performed an assay to see if these proteins added in trans
might affect NC-mediated strand transfer activity. NC (0.92 μM) was
added to reactions containing increasing amounts of the three
proteins (Fig. 4B). The ﬁrst bar in each panel (lanes 1, 6, and 11)
represents activity with NC alone. NC activity was unchanged in the
presence of the three proteins, although in the case of MA and to a
lesser extent MACA, there was a very small reduction in NC activity
when the concentrations of these two proteins were raised to 0.46 μM
(lanes 5 and 15).
Next we assayed the activity of two proteins that contain the NC
domain: (i) GagΔ16-99, which lacks a region in MA enriched with
basic residues; and (ii) CANC, which is missing all of MA (Fig. 1A). The
results in Fig. 5A demonstrate that both of these proteins retained the
ability to promote minus-strand transfer in a dose-dependent
manner, although the most signiﬁcant activity was in a narrow
range of protein concentration. Thus, for GagΔ16-99, maximal activity
was between 0.23 and 0.46 μM (lanes 6 and 7); this activity was
somewhat lower than that achieved with the optimal concentration
for Gag (0.12 μM) (Fig. 2B, lane 10). At a higher concentration of
GagΔ16-99 (0.92 μM) (lane 8), the reduction in strand transfer
activity wasmodest, unlike the complete abolition of this activity with
0.46 μM Gag (Fig. 2B, lane 12). The CANC protein behaved more like
Gag and stimulated maximal strand transfer between 0.12 and
0.23 μM (lanes 13 and 14). Moreover, adding higher concentrations
of CANC (0.46 and 0.92 μM, lanes 15 and 16 respectively) completelyeliminated strand transfer activity. In contrast to Gag or Gag WM,
neither the CANC nor the Gag Δ16-99 mutant was able to inhibit SP
(Fig. 5B). Since minus-strand transfer is inhibited at 0.46 and 0.92 μM
CANC, the reduction in SP products at these concentrations (lanes 15
and 16) probably reﬂects a general reduction in polymerase activity.
Collectively, the data in Figs. 4A and 5 demonstrate that the major
determinant for nucleic acid chaperone activity is the NC domain in
WT Gag and truncated Gag-derived proteins. While the MA domain
appears to contribute to chaperone activity in the context of Gag, the
absence of MA in an NC-containing partially processed Gag protein
such as CANC has a relatively small effect on strand transfer activity in
our system.
Kinetics of strand transfer and annealing
To further quantify differences in the nucleic acid chaperone
activities of Gag, CANC, and GagΔ16-99, we investigated the kinetics
of minus-strand transfer and annealing in a series of reactions
containing three different concentrations of each protein (0.06, 0.12,
and 0.23 μM) (Fig. 6). The optimal concentrations were 0.12 μM for Gag
(Fig. 6A–1) and CANC (Fig. 6B–1), whereas for GagΔ16-99, it was
0.23 μM(Fig. 6C–1). Note thatmaximal strand transfer (about 40%)was
achievedby30 minwith these concentrations and remainedunchanged
with further incubation for as long as 240 min (data not shown).
The rates of minus-strand transfer were calculated from the
experimental data for reactions with 0.12 μM(Table 2, middle column).
Of the three proteins, Gag had the highest kobs value (line 1). The rate for
CANC was only slightly reduced (1.3-fold) relative to the rate for Gag
(compare lines 1 and 2). In contrast, the rate for GagΔ16-99 (line 3)was
5-fold lower than the rate for Gag (compare lines 1 and 3). However, at
the optimal concentration for GagΔ16-99 (0.23 μM), the rate of strand
Fig. 5. Effect of GagΔ16-99 and CANC proteins on minus-strand transfer. Reaction mixtures were incubated for 60 min in the absence (No, open bars, 1 and 9) or presence of
increasing concentrations of GagΔ16-99 (cross-hatched bars, 2 to 8) and CANC (dark gray bars, 10 to 16). The concentrations (μM) of GagΔ16-99 and CANC, respectively, were the
same as those given for Gag in the legend to Fig. 2, except for the last points, i.e., at 0.92 μM. (A) and (B) Bar graphs. The % of minus-strand transfer product (A) and SP products (B)
synthesized was plotted as a function of GagΔ16-99 and CANC protein concentrations.
561T. Wu et al. / Virology 405 (2010) 556–567transfer was calculated as 0.125±020 min−1, i.e., 1.7-fold lower than
the rate for Gag and 1.4-fold lower than the rate for CANC. These results
indicate that when reactions contained optimal concentrations for each
protein, the rates were similar.
We also assayed the kinetics of annealing alone for each of the three
proteins. In each case, a concentration of 0.23 μM gave the greatest
amount of annealed product: almost 70% for Gag and CANC (Figs. 6A-2
and B-2, respectively) and over 60% for GagΔ16-99 (Fig. 6C-2). In
contrast to the strand transfer results, the maximal annealing levels
were reachedwithin 1 to 5 min. At a lower concentration, 0.12 μM, the
Gag reaction was signiﬁcantly more efﬁcient than the CANC and
GagΔ16-99 reactions.
The rates of minus-strand annealing were determined at a
concentration of 0.12 μM (Table 2, right column), since at a higher
concentration, the kinetics for Gag annealing were too fast to measure
(Fig. 6A-2). Interestingly, for all three proteins, the rates of annealing
were signiﬁcantly higher than the rates of strand transfer (Table 2,
compare middle column with right column). Gag had the highest rate
of annealing among the three proteins (Table 2, right column, line 1).
The rates for CANC and GagΔ16-99 were 2-fold and 5.4-fold lower,
respectively, than the rate for Gag (Table 2, right column, compare
line 1 with lines 2 and 3).
Collectively, these results demonstrate that raising the protein
concentration of Gag leads to increased stimulation of both the rate
and ﬁnal level of annealing, consistent with the end point data in Fig. 3
and in contrast with the strand transfer data (Figs. 2A and B).
Although the rates for strand transfer were lower than the rates for
annealing, it is interesting that in both assays, the ratio of the rate for
Gag to the rates for either CANC and GagΔ16-99 were very similar,
with activity ranked as GagNCANCNGagΔ16-99 (Table 2).Activity of Gag and partially processed Gag proteins in ERT assays
In addition to assays of Gag and Gag-derived proteins in our
reconstituted system, it was of interest to measure the activity of such
proteins in a viral setting. A series of HIV-1 mutants having mutations
at speciﬁc PR cleavage sites in Gagwas constructed by the Aiken group
(Wyma et al., 2004). These mutants include (i) MA/CA, (ii) MA/SP1,
(iii) MA/NC, and (iv) MA/p6 (uncleaved Gag) (Fig. 7). The absence of
an arrow at a site present inWT Gagmeans that cleavage is blocked at
that site in themutant (Fig. 7). Note that these mutations do not affect
cleavage of the Pol moiety in Gag-Pol and RT is expressed as the
mature protein.
Initial efforts to analyze synthesis of viral DNA products in cells
infected with these virions were unsuccessful, since the amounts of
DNA detected were very low and therefore highly variable. However,
it was possible to perform ERT assays with detergent-treated virions
and to measure minus-strand transfer efﬁciency, i.e., the amount of
extended minus-strand DNA (U3-U5) divided by the amount of (−)
SSDNA (R-U5), by qPCR analysis of the DNA products (Table 3).
Interestingly, for thosemutants able to generatemature NC, i.e., MA/CA
and MA/SP1, minus-strand transfer efﬁciency essentially matched that
observed for WT. The MA/NC virus, which contains uncleaved NC, had
55% of WT activity. MA/p6 (uncleaved Gag) exhibited ~30% of WT
activity, presumably reﬂecting a low level of strand transfer facilitated
by Gag. This is consistent with our ﬁnding in the reconstituted system
that under some conditions, small amounts of the strand transfer
product could be detected in reactions containing Gag and an increased
concentration of RT (data not shown). In addition, some of the Gag
activity could be due to the fact that in addition to uncleaved Gag,
mutant virions were shown to contain some MA/NC (Wyma et al.,
Fig. 6. Kinetics of minus-strand transfer and annealing in the presence of Gag, CANC, and GagΔ16-99. Reaction mixtures were incubated from 1 to 60 min (minus-strand transfer) or
1 min to 30 min (annealing) at 37 °C with different concentrations of Gag (A), CANC (B), or GagΔ16-99 (C). The % of minus-strand transfer product (A-1, B-1, C-1) and annealed
product (A-2, B-2, C-2) were plotted against time of incubation. Symbols: Minus-strand transfer, closed symbols; annealing, open symbols. Protein concentrations were as follows:
no protein, diamonds, dashed lines; 0.06 μM, squares, 0.12 μM, inverted triangles; and 0.23 μM, circles. Only one set of minus protein values for either theminus-strand transfer (A-1,
B-1, C-1) or annealing reactions (A-2, B-2, C-2) is shown. Note that in this series of experiments, the values for Gag-mediated minus-strand transfer at a concentration of 0.23 μM
were close to baseline, similar to what was seen at 0.46 μM in Fig. 2. This is due to the fact that a different Gag preparation was used here. We have found that there is some variation
between preparations, but the extent of variation is relatively small and does not affect the overall conclusions.
562 T. Wu et al. / Virology 405 (2010) 556–5672004). (All of the other cleavage mutants contain only the predicted
proteins (Wyma et al., 2004).) The negative control for these
experiments was the viral mutant PRD25G (Ott et al., 2000) with a
mutation in the PR active site.
Taken together, these results demonstrate that Gag and partially
processed Gag proteins with the NC domain are able to promote
minus-strand transfer in detergent-treated virus particles as well as in
a reconstituted system with puriﬁed components. In virions where
mature NC could be formed, activity was not affected by the presence
of a partially processed Gag fragment, consistent with the results of
Fig. 4B.Discussion
The goal of the present study was to determine the effect on the
nucleic acid chaperone activity of HIV-1 NC when it is embedded in
Gag or partially processed Gag proteins. A positive result in the assay
we use (Fig. 1C) is dependent upon the characteristic activities of a
nucleic acid chaperone: (i) ability to facilitate annealing and weak
destabilization of nucleic acid secondary structure and (ii) rapid
nucleic acid binding/dissociation kinetics (Cruceanu et al., 2006a,b;
Darlix et al., 2007; Levin et al., 2005; Rein et al., 1998). Here, we show
for the ﬁrst time, that Gag has both annealing and duplex
Table 3
Minus-strand transfer efﬁciency in ERT assays.
Virus Minus-strand transfer efﬁciency (%)a,b
WT 102±7
MA/CA 99±27
MA/SP1 96±10
MA/NC 55±6
MA/p6 29±3
PRD25Gc 8±0.4
a Minus-strand transfer efﬁciency expressed as a percentage of U3-U5/R-U5 copies.
b Numbers to the left of the “±” are the percent efﬁciencies and those to the right are
the standard deviations of values from two independent experiments.
c pNL4-3 with an active site mutation that inactivates PR.
Table 2
Rates of strand transfer or annealing (kobs values)a.
Proteinb Rates of strand transfer (min−1) Rates of annealing (min−1)
Gag 0.22±0.027 0.75±0.059
CANC 0.17±0.027 0.38±0.094
GagΔ16-99 0.044±0.003 0.14±0.032
a Rates were determined by ﬁtting the data to a single exponential equation.
b The concentration of each protein was 0.12 μM.
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reduce SP. NC reaches a higher end point value for strand transfer and
suppresses SP more efﬁciently than Gag, suggesting that NC's duplex
destabilization activity is more effective than that of the precursor
protein. However, relatively high concentrations of NC are required for
maximal activity (Fig. 2).
The results alsodemonstrate that theNCdomain inGag is crucial for its
chaperone function in strand transfer, in accord with studies on primer
placement with Gag (Cen et al., 2000; Feng et al., 1999; Guo et al., 2009)
and Gag-derived proteins (Chan et al., 1999; Roldan et al., 2005). In vitro,
mature NC also promotes primer placement (Cen et al., 2000; Feng et al.,
1999; Hargittai et al., 2001; Iwatani et al., 2007; Prats et al., 1988; Rong et
al., 1998; Tisné et al., 2001); for more detailed discussion and references,
see Levin et al., 2005). Thus, CANC or GagΔ16-99, which have an NC
domain, but are lacking all or a large portion ofMA, respectively, facilitate
strand transfer (Figs. 5 and 6), whereas proteins without an NC domain,
e.g., MA, CA, and MACA do not (Fig. 4). The more effective chaperone
activity of Gag in comparison to GagΔ16-99 in our assay system suggests
that in the context ofWT Gag, the NC domain binds and concentrates the
nucleic acid, which allows additional binding by MA, thereby enhancing
chaperone activity (Datta et al., 2007a). Studies of GagWMsuggest that it
adopts a variety of compact conformations, allowing the MA and NC
domains to be near each other (Datta et al., 2007a). More recent work
provides evidence that nucleic acid interaction with highly basic residues
in theMA domain of Gag, in addition to interactions with the NC domain,
regulates Gag binding to lipid membranes (Chukkapalli et al., 2010). The
difference in the activities of Gag andCANCmight bedue to the lack ofMA
in CANC and/or different folds of the CA N-terminal domain (NTD) in the
two proteins (von Schwedler et al., 2003).
In reactions that only measure the annealing step in minus-strand
transfer, Gag, Gag WM, and NC all reach the same end point, but a
much higher concentration of NC is needed compared with the
concentrations of the other two proteins (Fig. 3). This observation is
consistent with FA analysis showing that Gag and Gag WM have
signiﬁcantly greater afﬁnity for binding to ssDNA or RNA than NC
(Table 1) and also with earlier data (Cruceanu et al., 2006b; Roldan et
al., 2004; Roldan et al., 2005). Interestingly, both the extent and rate of
Gag annealing are also higher than the corresponding values for CANCFig. 7. Minus-strand transfer efﬁciency in ERT reactions with virions containing HIV-1
WT Gag or partially processed Gag proteins. HIV-1 WT Gag and Gag mutants blocked at
PR cleavage sites. The schematic diagram shows Gag and partially processed Gag
proteins resulting from mutation of cleavage sites (Wyma et al., 2004). The arrows
indicate the PR cleavage sites inWTGag. The absence of an arrow at a site present inWT
Gag indicates that cleavage at that site is blocked in the mutant.and GagΔ16-99 (Fig. 6; Table 2). This difference in annealing activity
may account, at least in part, for the fact that these two proteins are
unable to inhibit SP (Fig. 5), which occurs only when (−) SSDNA
exists in an unannealed form (Guo et al., 1997). Note that in both the
annealing and strand transfer assays the order of activity is
GagNCANCNGagΔ16-99.
A major ﬁnding of this study is the observation that when the
concentrations of Gag or Gag WM are ≥0.23 μM, DNA elongation is
signiﬁcantly reduced or abolished completely (Fig. 2). This phenom-
enon was also observed with CANC and GagΔ16-99, although the
effect was less dramatic with the deletion mutant (Fig. 5). Indeed, a
common feature of proteins exhibiting concentration-dependent
inhibition of polymerization is that they all contain the CA, SP1, and
NC domains. Interestingly, the blocking effect is correlated with the
behavior of Gag in single-molecule DNA stretching experiments
(Cruceanu et al., 2006b), a technique that gives information on nucleic
acid binding kinetics (Williams et al., 2009). In studies of Gag and NC,
Cruceanu et al. (Cruceanu et al., 2006a,b) demonstrated that NC has a
high on-off rate, whereas Gag, once bound to the ssDNA or RNA
template, dissociates very slowly. Indeed, even with relatively low
concentrations of Gag, it can act as a roadblock to DNA extension,
whereas fully processed NC allows RT to continue elongating the DNA
or RNA primer (Figs. 2A and B). Thus, Gag lacks a critical property of
highly functional nucleic acid chaperones such as HIV-1 NC (Cruceanu
et al., 2006a). Recently, it was reported that the poor chaperone
activity of HTLV-1 NC is also correlated with slow dissociation kinetics
(Qualley et al., 2010). In addition, Iwatani et al. (Iwatani et al., 2007)
found that a roadblock mechanism could explain the deaminase-
independent inhibitory effect of APOBEC3G on DNA polymerization
reactions catalyzed by HIV-1 RT (Bishop et al., 2008; Iwatani et al., 2007).
These considerations led us to ask: (i) What causes Gag's slow
dissociation from bound nucleic acid and the resulting roadblock to
RT-catalyzed DNA extension? and (ii) Why are there negligible
differences between GagΔp6 and Gag WM activity in the strand
transfer assay? In addressing these questions, it is important to note
that in the absence of nucleic acid, Gag multimerizes at protein
concentrations in the μM range, whereas 95% of Gag WM is
monomeric (Datta et al., 2007a). However, in the presence of nucleic
acid (the condition that prevails in our assays), both Gag and GagWM
bind to nucleic acid with similar afﬁnity (Table 1) and can engage in
speciﬁc protein–protein interactions, mediated by the CA domain
(Datta et al., 2007a; Stephen et al., 2007). We refer to this as “nucleic
acid-driven multimerization”. Indeed, the fact that Gag WM can
assemble into VLPs in vivo, albeit with lower efﬁciency and higher
heterogeneity when bound to nucleic acid (Datta et al., 2007a),
suggests that this protein can recapitulate basic protein–protein
interactions necessary for VLP formation. Thus, both Gag and GagWM
can effectively inhibit strand transfer by the roadblock mechanism. In
principle, such a mechanism could inhibit premature initiation of
reverse transcription. However, at present, it is not knownwhether RT
is released from Gag-Pol before PR cleavage of Gag or whether HIV-1
Gag-Pol can catalyze reverse transcription in the infected cell.
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RNA duplex was annealed by GagΔp6 or a mini-Gag protein, which in
each case remained in the reaction mixtures throughout the incubation,
elongationof the tRNAprimerwaseither completelyoralmost completely
inhibited, respectively. In their system, DNA extension following anneal-
ing was more efﬁcient with a mini-Gag dimerization mutant than with
WTmini-Gag (Roldan et al., 2005), a result that contrastswith ourﬁnding
that Gag and GagWMhave very similar activities (Figs. 2 and 3). Gag and
mini-Gag caneach interactwithnucleic acids, resulting inprotein–protein
interactions.However, it is likely that themini-Gag–mini-Gag interactions
are not as stable as the Gag–Gag interactions observed in our study, since
the mini-Gag construct is missing the NTD of CA, which contributes to
stabilization of the protein multimers. Thus, the monomeric mini-Gag
mutant has greater activity than theWT protein, whereas the strength of
the Gag–Gag interactions even with Gag WM is sufﬁcient to block DNA
elongation.
Another issue that we address is the behavior of Gag and partially
processed Gag proteins in our reconstituted strand transfer system
and the effects of such proteins in a viral setting. For this work, we
took advantage of a series of HIV-1 viral mutants that are blocked at
one or more Gag cleavage sites and do not have conical cores (Wyma
et al., 2004). Since attempts to assay viral DNA products synthesized
in infected cells were unsuccessful, we chose to measure ERT activity
in detergent-treated virions (Fig. 7; Table 3). In this assay, the lack of
conical cores per se does not block reverse transcription (Kaplan et al.,
1994; Tang et al., 2001) (Thomas, J.A. and Gorelick, R.J., unpub. obs.).
The results of the ERT assays are consistent with the data from the
reconstituted system. In particular, we note that transdominant
effects of partially processed Gag proteins, which could potentially
inhibit NC activity in our experiments, are not observed in either assay
(Fig. 4B; Table 3), in contrast to the situation with virus-infected cells
(Checkley et al., 2010; Lee et al., 2009; Müller et al., 2009; Rulli et al.,
2006). Thus, transdominant inhibition of viral DNA synthesis by Gag
cleavage proteins occurs only in a cell-based system where a block in
Gag cleavage is closely linked to (i) the assembly of aberrant viral
cores and/or (ii) improper uncoating of cores following virus entry
into the cell.
In summary, we have demonstrated that there is a major
difference between the nucleic acid chaperone activities of NC
embedded in HIV-1 Gag and Gag-derived proteins and those of
mature NC. Although all of these proteins have annealing and helix
destabilizing activities, the activity of Gag proteins is less effective
than that of mature NC. Thus, unlike NC, Gag dissociates slowly from
bound nucleic acid, a consequence of nucleic acid-driven Gag
multimerization that occurs even at relatively low protein concentra-
tions. This in turn leads to drastic inhibition of DNA elongation. We
refer to this inhibition as the roadblock mechanism. It will be
interesting to determine whether this mechanism is used more
generally by other retroviruses. In conclusion, our data help to explain
why NC and not Gag is a critical cofactor for viral DNA synthesis and
illustrate how the presence of NC in a multi-domain protein like Gag
modulates the nature of its nucleic acid chaperone activity.
Materials and methods
Materials
DNA oligonucleotides were obtained from Lofstrand (Gaithers-
burg, MD) and Integrated DNA Technologies (Coralville, IA). T4
polynucleotide kinase, proteinase K, SUPERaseIN, and Gel Loading
Buffer II were obtained fromApplied Biosystems (Foster City, CA). [γ-33P]
ATP (3,000 Ci/mmol) was purchased from PerkinElmer (Shelton, CT). All
of the columns used for protein puriﬁcation were purchased from GE
Healthcare Life Sciences (Piscataway, NJ). HIV-1 RT was obtained from
Worthington (Lakewood, NJ). The sequence of NC and the nucleic acids
used in this study were derived from the HIV-1 pNL4-3 clone (GenBankaccession no. AF324493) (Adachi et al., 1986). Sequences of the puriﬁed
Gag and Gag cleavage proteins were derived fromHIV-1 BH10 (GenBank
accession no. M15654.1) (Campbell and Rein, 1999; Ratner et al., 1985),
except for GagΔ16-99, which contains sequences from HIV-1 NL4-3 and
BH10 (SpeI site in CA to 3′ end is BH10) (Gross et al., 2000).
Puriﬁcation of proteins used in this study
Gag and Gag cleavage products (Fig. 1A) were expressed in BL21
(DE3)pLysS cells (Stratagene). Cells expressing HIV-1 matrix (MA)
were induced at 37 °C for 4 h with 1 mM isopropyl-beta-D-thioga-
lactoside and were lysed in buffer A (20 mM Tris–HCl, pH 7.4, 10 mM
2-mercaptoethanol, and 1 mMphenylmethylsulfonyl ﬂuoride [Sigma-
Aldrich]) containing 150 mM NaCl. After centrifugation at 12,000×g
for 15 min to remove cellular debris, theMA proteinwas puriﬁed from
the total lysate by taking a 40–70% ammonium sulfate cut. The protein
was dialyzed against buffer A containing 150 mM NaCl. After dialysis,
ammonium sulfate was added to 40% saturation and the protein was
chromatographed on a Butyl Sepharose column. Fractions containing
the protein were dialyzed against buffer A with 50 mMNaCl and were
run on an SP® Sepharose column. The puriﬁed protein was stored at
−80 °C in buffer A with 150 mMNaCl and 10% Glycerol. HIV-1 CA and
MACA were puriﬁed as described in references (von Schwedler et al.,
1998; Yoo et al., 1997), respectively.
Since HIV-1 Gag expressed in E. coli is extensively degraded by
bacterial proteases (Campbell and Rein, 1999), the stably expressed
protein known as GagΔp6 was used instead of authentic Gag in assays
for minus-strand transfer. Note that in addition to missing the p6
domain, GagΔp6 is not myristoylated at its N-terminus (Campbell and
Rein, 1999). GagΔp6 proteins with additional changes were as
follows: (i) GagΔ16-99, missing residues 16–99 in the MA domain
(Datta and Rein, 2009; Fäcke et al., 1993; Gross et al., 2000) and (ii)
Gag WM, GagΔp6 with Trp316 and Met317 (i.e., Trp184 and Met185
in CA, respectively) changed to Ala, which causes a defect in Gag
dimerization (Datta et al., 2007a,b). GagΔp6, the two GagΔp6-derived
proteins, and CANC (Campbell and Vogt, 1995) were puriﬁed by
phosphocellulose afﬁnity chromatography as described previously
(Datta et al., 2007a; Datta and Rein, 2009). In the ﬁnal puriﬁcation
step, the proteins were subjected to further chromatography on
Superose 12 (GagΔp6, GagΔ16-99, Gag WM, CANC) or Superdex 75
(MA, MACA, CA) gel ﬁltration columns to eliminate RNase and DNase
contamination. Analysis of the Gag and Gag-derived protein prepara-
tions by SDS–PAGE indicated that the proteins were at least 90% pure
(Fig. 1B). The residue numbers in Gag and the respectivemolecularmass
values are given in the legend to Fig. 1B. Recombinant HIV-1 NC was
prepared as described previously (Carteau et al., 1999; Wu et al., 1996).
In vitro minus-strand transfer assay
The minus-strand transfer assay was performed as described
previously (Heilman-Miller et al., 2004) with several changes. Since
maximal activity was obtained at 1mMMg2+ in reactions with either
NC (Wu et al., 2007) or Gag (data not shown), we used 1 mMMg2+ in
all of the polymerase reactions. In addition, 0.5 U of SUPERaseIN was
added per 20-μl reaction. HIV-1 NC or Gag and Gag-derived proteins
were added at the concentrations speciﬁed in the legends to the
ﬁgures. Reaction mixtures (ﬁnal volume, 20 μl) also contained DNA
128 ((−) SSDNA) labeled at its 5′ end with 33P, using the 32P labeling
protocol described in Guo et al. (1995), RNA 148 (acceptor RNA), and
HIV-1 RT, each at a ﬁnal concentration of 10 nM. Incubation was at
37 °C for the indicated times. Termination of the reactions, electro-
phoresis in denaturing gels, and PhosphorImager analysis were
performed as described (Wu et al., 2007). In addition to the transfer
product, dead-end products caused by SP of fold-back structures at
the 3′ end of (−) SSDNA (Beltz et al., 2005; Driscoll and Hughes, 2000;
Guo et al., 1997, 2000; Heilman-Miller et al., 2004; Lapadat-Tapolsky
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formed. The percentage of minus-strand transfer product synthesized
was calculated by dividing the amount of transfer product by total
DNA (transfer product plus SP products and remaining DNA 128),
multiplied by 100. The percentage of SP products synthesized was
calculated in a similar manner. The data for strand transfer and for
annealing (see below) represent the average of results obtained in at
least three independent experiments. Error bars shown in the ﬁgures
represent the standard deviation.
Annealing assay
33P-labeled DNA 128 (0.2 pmol) was incubated at 37 °C with 0.2
pmol of RNA 148 in buffer containing 50 mM Tris–HCl (pH 8.0) and
75 mM KCl for the indicated times in the absence or presence of Gag
proteins (ﬁnal volume, 20 μl), as described (Wu et al., 2007). The ﬁnal
concentration of the nucleic acid substrates was 10 nM.
Fluorescence anisotropy (FA) experiments
Equilibrium binding of HIV-1 NC and Gag to a 20-nt AlexaFluor-
488-labeled ss DNA oligonucleotide (JL936, 5′-Alex488-
AGCTGCTTTTTGCCTGTACT-3′) and a 20-nt ﬂuorescein-labeled ssRNA
oligonucleotide (JL943, 5′-Fl-AGCUGCUUUUUGCCUGUACU-3′) was
measured using FA. The oligonucleotides contained the 20-nt ssRNA
or DNA sequence from the extreme 3′ terminus of U3. JL936 (puriﬁed
by high performance liquid chromatography) and JL943 (puriﬁed by
PAGE) were obtained from Integrated DNA Technologies (Coralville,
IA) and Dharmacon, Inc. (Lafayette, CO), respectively. FA measure-
ments were performed in Corning® 384-well low volume black
polystyrene NBSTM microplates (Corning, NY) using a SpectraMax®
M5multimodemicroplate reader (Molecular Devices, Sunnyvale, CA).
JL936 or JL943 (each 20 nM) were incubated with increasing
concentrations of NC or Gag in 50 mM Tris–HCl (pH 8.0), 75 mM KCl,
1 mM MgCl2, and 1 mM DTT. Samples were excited at 485 nm and
emission intensities at both parallel and perpendicular planes were
collected at 525 nm. The resulting plot of anisotropy vs. protein
concentration was ﬁt using a one-site binding model (Iwatani et al.,
2007) to obtain the Kd value.
Virus production
Viruses were derived by transfection of 293 T cells in 100-mm
culture dishes, using the CaPO4/DNA coprecipitation method (Gra-
raham and van der Eb, 1973), as described previously (Thomas et al.,
2008). Plasmids for the production of the MA/CA, MA/SP1, MA/NC,
and MA/p6 mutant viruses (Wyma et al., 2004) were a generous gift
from Christopher Aiken, Vanderbilt University Medical Center, Nash-
ville, TN. The PR mutant, PRD25G, was a generous gift from David Ott,
SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD (Ott et al., 2000).
TheWTHIV-1 plasmid pNL4-3 (Adachi et al., 1986)was obtained from
Malcolm Martin (NIAID, NIH) through the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID, NIH.
ERT assays
Viral supernatant ﬂuids (30 ml) were treated with DNase I and
were then pelleted through a 5-ml 20% (w/v) sucrose cushion (in PBS
without Ca2+ or Mg2+) in a Beckman SW32 rotor at 144,000×g for 1 h
at 4 °C. The pellets were resuspended and subjected to ERT as
described previously (Thomas et al., 2008). Reverse transcription
products, R-U5 (representative of (−) SSDNA products), and U3-U5
(representative ofminus-strand transfer products)were quantiﬁed by
qPCR, as described previously (Buckman et al., 2003).Acknowledgments
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